women's health in south tyneside
women's health in south tyneside Company Information
Company Number
06175697
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
salus house 33 & 35 mile end roa, mile end road, south shields, tyne and wear, NE33 1TA
Website
http://whist.org.ukwomen's health in south tyneside Estimated Valuation
Pomanda estimates the enterprise value of WOMEN'S HEALTH IN SOUTH TYNESIDE at £268.1k based on a Turnover of £479.6k and 0.56x industry multiple (adjusted for size and gross margin).
women's health in south tyneside Estimated Valuation
Pomanda estimates the enterprise value of WOMEN'S HEALTH IN SOUTH TYNESIDE at £0 based on an EBITDA of £-49.6k and a 4.25x industry multiple (adjusted for size and gross margin).
women's health in south tyneside Estimated Valuation
Pomanda estimates the enterprise value of WOMEN'S HEALTH IN SOUTH TYNESIDE at £2.9m based on Net Assets of £1.1m and 2.49x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Women's Health In South Tyneside Overview
Women's Health In South Tyneside is a live company located in south shields, NE33 1TA with a Companies House number of 06175697. It operates in the other human health activities sector, SIC Code 86900. Founded in March 2007, it's largest shareholder is unknown. Women's Health In South Tyneside is a established, micro sized company, Pomanda has estimated its turnover at £479.6k with low growth in recent years.
Upgrade for unlimited company reports & a free credit check
Women's Health In South Tyneside Health Check
Pomanda's financial health check has awarded Women'S Health In South Tyneside a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
6 Weak
Size
annual sales of £479.6k, make it smaller than the average company (£730.1k)
£479.6k - Women's Health In South Tyneside
£730.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (7.2%)
3% - Women's Health In South Tyneside
7.2% - Industry AVG
Production
with a gross margin of 38.3%, this company has a comparable cost of product (38.3%)
38.3% - Women's Health In South Tyneside
38.3% - Industry AVG
Profitability
an operating margin of -16.3% make it less profitable than the average company (5.1%)
-16.3% - Women's Health In South Tyneside
5.1% - Industry AVG
Employees
with 10 employees, this is below the industry average (19)
10 - Women's Health In South Tyneside
19 - Industry AVG
Pay Structure
on an average salary of £34.6k, the company has a higher pay structure (£26.5k)
£34.6k - Women's Health In South Tyneside
£26.5k - Industry AVG
Efficiency
resulting in sales per employee of £48k, this is equally as efficient (£45.5k)
£48k - Women's Health In South Tyneside
£45.5k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (20 days)
5 days - Women's Health In South Tyneside
20 days - Industry AVG
Creditor Days
its suppliers are paid after 15 days, this is quicker than average (18 days)
15 days - Women's Health In South Tyneside
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Women's Health In South Tyneside
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 272 weeks, this is more cash available to meet short term requirements (127 weeks)
272 weeks - Women's Health In South Tyneside
127 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 6.5%, this is a lower level of debt than the average (22%)
6.5% - Women's Health In South Tyneside
22% - Industry AVG
WOMEN'S HEALTH IN SOUTH TYNESIDE financials
Women'S Health In South Tyneside's latest turnover from March 2024 is £479.6 thousand and the company has net assets of £1.1 million. According to their latest financial statements, Women'S Health In South Tyneside has 10 employees and maintains cash reserves of £415 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 479,637 | 430,498 | 513,144 | 441,080 | 308,264 | 276,528 | 276,989 | 343,472 | 328,656 | 585,477 | 435,468 | 311,215 | 282,472 | 283,911 | 246,831 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 116 | 110 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | -55,694 | -50,468 | 88,868 | 89,034 | -16,075 | -103,142 | -76,861 | -3,591 | -4,060 | 272,780 | 141,608 | 32,989 | 20,058 | 9,586 | -28,641 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -55,694 | -50,468 | 88,868 | 89,034 | -16,075 | -103,142 | -76,861 | -3,591 | -4,060 | 272,780 | 141,608 | 32,989 | 20,058 | 9,586 | -28,641 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | -55,694 | -50,468 | 88,868 | 89,034 | -16,075 | -103,142 | -76,861 | -3,591 | -4,060 | 272,780 | 141,608 | 32,989 | 20,058 | 9,586 | -28,641 |
| Employee Costs | 346,412 | 355,685 | 298,675 | 218,990 | 196,011 | 256,277 | 226,295 | 192,632 | 201,058 | 197,892 | 203,022 | 195,740 | 188,218 | 183,973 | 179,069 |
| Number Of Employees | 10 | 11 | 9 | 7 | 6 | 8 | 8 | 7 | 7 | 7 | 8 | 7 | 7 | 7 | 7 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 752,955 | 779,763 | 807,384 | 829,955 | 836,363 | 859,955 | 893,334 | 929,348 | 945,720 | 978,659 | 693,147 | 585,878 | 587,195 | 587,917 | 607,173 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 752,955 | 779,763 | 807,384 | 829,955 | 836,363 | 859,955 | 893,334 | 929,348 | 945,720 | 978,659 | 693,147 | 585,878 | 587,195 | 587,917 | 607,173 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 7,870 | 23,180 | 8,555 | 1,175 | 4,284 | 22 | 3,990 | 9,818 | 2,342 | 405 | 1,640 | 10,895 | 8,650 | 11,468 | 11,560 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 51,274 | 1,482 | 8,065 | 8,026 | 7,413 | 7,848 | 6,606 | 5,077 | 6,580 | 14,375 | 10,891 | 4,955 | 4,600 | 2,275 | 4,763 |
| Cash | 415,012 | 433,975 | 445,739 | 346,438 | 255,919 | 248,464 | 305,577 | 345,048 | 355,461 | 330,093 | 311,390 | 276,693 | 250,464 | 252,947 | 238,932 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 474,156 | 458,637 | 462,359 | 355,639 | 267,616 | 256,334 | 316,173 | 359,943 | 364,383 | 344,873 | 323,921 | 292,543 | 263,714 | 266,690 | 255,255 |
| total assets | 1,227,111 | 1,238,400 | 1,269,743 | 1,185,594 | 1,103,979 | 1,116,289 | 1,209,507 | 1,289,291 | 1,310,103 | 1,323,532 | 1,017,068 | 878,421 | 850,909 | 854,607 | 862,428 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 12,801 | 2,499 | 5,657 | 8,073 | 2,371 | 3,854 | 4,133 | 5,895 | 3,620 | 32,385 | 317 | 4,488 | 735 | 32 | 4,808 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 66,456 | 32,353 | 10,070 | 12,373 | 25,494 | 20,246 | 10,043 | 11,204 | 30,700 | 11,304 | 9,688 | 8,478 | 17,708 | 42,167 | 54,798 |
| total current liabilities | 79,257 | 34,852 | 15,727 | 20,446 | 27,865 | 24,100 | 14,176 | 17,099 | 34,320 | 43,689 | 10,005 | 12,966 | 18,443 | 42,199 | 59,606 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 79,257 | 34,852 | 15,727 | 20,446 | 27,865 | 24,100 | 14,176 | 17,099 | 34,320 | 43,689 | 10,005 | 12,966 | 18,443 | 42,199 | 59,606 |
| net assets | 1,147,854 | 1,203,548 | 1,254,016 | 1,165,148 | 1,076,114 | 1,092,189 | 1,195,331 | 1,272,192 | 1,275,783 | 1,279,843 | 1,007,063 | 865,455 | 832,466 | 812,408 | 802,822 |
| total shareholders funds | 1,147,854 | 1,203,548 | 1,254,016 | 1,165,148 | 1,076,114 | 1,092,189 | 1,195,331 | 1,272,192 | 1,275,783 | 1,279,843 | 1,007,063 | 865,455 | 832,466 | 812,408 | 802,822 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 28,366 | 28,428 | 27,898 | 24,373 | 25,722 | 33,539 | 36,262 | 34,273 | 33,371 | 22,782 | 16,097 | 2,538 | 3,110 | 19,256 | 19,845 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 34,482 | 8,042 | 7,419 | -2,496 | 3,827 | -2,726 | -4,299 | 5,973 | -5,858 | 2,249 | -3,319 | 2,600 | -493 | -2,580 | 16,323 |
| Creditors | 10,302 | -3,158 | -2,416 | 5,702 | -1,483 | -279 | -1,762 | 2,275 | -28,765 | 32,068 | -4,171 | 3,753 | 703 | -4,776 | 4,808 |
| Accruals and Deferred Income | 34,103 | 22,283 | -2,303 | -13,121 | 5,248 | 10,203 | -1,161 | -19,496 | 19,396 | 1,616 | 1,210 | -9,230 | -24,459 | -12,631 | 54,798 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116 | -110 |
| cash flow from financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -116 | 831,353 |
| cash and cash equivalents | |||||||||||||||
| cash | -18,963 | -11,764 | 99,301 | 90,519 | 7,455 | -57,113 | -39,471 | -10,413 | 25,368 | 18,703 | 34,697 | 26,229 | -2,483 | 14,015 | 238,932 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -18,963 | -11,764 | 99,301 | 90,519 | 7,455 | -57,113 | -39,471 | -10,413 | 25,368 | 18,703 | 34,697 | 26,229 | -2,483 | 14,015 | 238,932 |
women's health in south tyneside Credit Report and Business Information
Women's Health In South Tyneside Competitor Analysis
Perform a competitor analysis for women's health in south tyneside by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in NE33 area or any other competitors across 12 key performance metrics.
women's health in south tyneside Ownership
WOMEN'S HEALTH IN SOUTH TYNESIDE group structure
Women'S Health In South Tyneside has no subsidiary companies.
Ultimate parent company
WOMEN'S HEALTH IN SOUTH TYNESIDE
06175697
women's health in south tyneside directors
Women'S Health In South Tyneside currently has 7 directors. The longest serving directors include Miss Andonia Di Stefano (Mar 2007) and Ms Judith Taylor (Aug 2019).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Miss Andonia Di Stefano | 71 years | Mar 2007 | - | Director | |
| Ms Judith Taylor | 65 years | Aug 2019 | - | Director | |
| Miss Anna Shields | United Kingdom | 39 years | Aug 2019 | - | Director |
| Mrs Anna Kozaczek | United Kingdom | 43 years | Sep 2020 | - | Director |
| Ms Jayne Daglish | United Kingdom | 58 years | Sep 2021 | - | Director |
| Miss Sarah Hewitt | United Kingdom | 25 years | Mar 2023 | - | Director |
| Mrs Susan Key | United Kingdom | 76 years | Mar 2023 | - | Director |
P&L
March 2024turnover
479.6k
+11%
operating profit
-78k
0%
gross margin
38.4%
+2.26%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.1m
-0.05%
total assets
1.2m
-0.01%
cash
415k
-0.04%
net assets
Total assets minus all liabilities
women's health in south tyneside company details
company number
06175697
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
March 2007
age
18
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
CLAIRE MILLER
auditor
-
address
salus house 33 & 35 mile end roa, mile end road, south shields, tyne and wear, NE33 1TA
Bank
VIRGIN MONEY
Legal Advisor
WARD HADAWAY
women's health in south tyneside Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to women's health in south tyneside.
women's health in south tyneside Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for WOMEN'S HEALTH IN SOUTH TYNESIDE. This can take several minutes, an email will notify you when this has completed.
women's health in south tyneside Companies House Filings - See Documents
| date | description | view/download |
|---|
